Bank of New York Mellon »

Lb Pharmaceuticals shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Lb Pharmaceuticals (LBRX) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Lb Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Lb Pharmaceuticals held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lb Pharmaceuticals by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2025-12-31 $902k 41k 22.26

More positions owned by Bank of New York Mellon

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Inc-cl A Cap (GOOGL)
Broadcom (AVGO)
Meta Platforms Inc-class A Cl A (META)
Alphabet Inc-cl C Cap (GOOG)
Ishares Core S&p 500 Etf Core (IVV)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Berkshire Hathaway Inc-cl B CL B (BRK.B)
Exxon Mobil Corporation (XOM)
Eli Lilly & Co. (LLY)
Johnson & Johnson (JNJ)

View all positions for Bank of New York Mellon

Top funds holding Lb Pharmaceuticals

Deep Track Capital
RA Capital Management
TCG Crossover Management
Commodore Capital
Logos Global Management
Vanguard Group
Jpmorgan Chase & Co
BlackRock
Balyasny Asset Management
Jennison Associates
Vivo Capital
Nantahala Capital Management
Alyeska Investment Group
Citadel Advisors
Millennium Management

View all funds holding Lb Pharmaceuticals